ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $16,611,000 | -5.0% | 3,104,916 | -0.0% | 0.00% | -33.3% |
Q3 2016 | $17,484,000 | +4.0% | 3,105,497 | +1.4% | 0.00% | 0.0% |
Q2 2016 | $16,808,000 | -25.6% | 3,061,630 | +0.5% | 0.00% | -25.0% |
Q1 2016 | $22,601,000 | -10.2% | 3,045,989 | +0.6% | 0.00% | 0.0% |
Q4 2015 | $25,163,000 | -3.9% | 3,028,007 | +4.2% | 0.00% | -20.0% |
Q3 2015 | $26,175,000 | -18.1% | 2,905,150 | +9.1% | 0.01% | 0.0% |
Q2 2015 | $31,957,000 | +17.3% | 2,663,092 | +5.3% | 0.01% | +25.0% |
Q1 2015 | $27,244,000 | +342.4% | 2,529,645 | +108.3% | 0.00% | +300.0% |
Q4 2014 | $6,158,000 | +137.8% | 1,214,646 | +23.8% | 0.00% | – |
Q3 2014 | $2,590,000 | -38.8% | 981,120 | -6.6% | 0.00% | -100.0% |
Q2 2014 | $4,235,000 | -20.8% | 1,050,798 | -9.9% | 0.00% | 0.0% |
Q1 2014 | $5,344,000 | +18.6% | 1,166,732 | +12.4% | 0.00% | 0.0% |
Q4 2013 | $4,506,000 | +21.0% | 1,038,189 | +9.8% | 0.00% | 0.0% |
Q3 2013 | $3,725,000 | +95.8% | 945,547 | +4.9% | 0.00% | – |
Q2 2013 | $1,902,000 | – | 901,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |